476 related articles for article (PubMed ID: 2497225)
1. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
Stuehr DJ; Nathan CF
J Exp Med; 1989 May; 169(5):1543-55. PubMed ID: 2497225
[TBL] [Abstract][Full Text] [Related]
2. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide.
Stuehr DJ; Gross SS; Sakuma I; Levi R; Nathan CF
J Exp Med; 1989 Mar; 169(3):1011-20. PubMed ID: 2784476
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.
Kwon NS; Stuehr DJ; Nathan CF
J Exp Med; 1991 Oct; 174(4):761-7. PubMed ID: 1717630
[TBL] [Abstract][Full Text] [Related]
4. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.
Marletta MA; Yoon PS; Iyengar R; Leaf CD; Wishnok JS
Biochemistry; 1988 Nov; 27(24):8706-11. PubMed ID: 3242600
[TBL] [Abstract][Full Text] [Related]
5. Failure to induce nitric oxide production by human monocyte-derived macrophages. Manipulation of biochemical pathways.
Arias M; Zabaleta J; Rodríguez JI; Rojas M; París SC; García LF
Allergol Immunopathol (Madr); 1997; 25(6):280-8. PubMed ID: 9469204
[TBL] [Abstract][Full Text] [Related]
6. Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release.
Bernard C; Szekely B; Philip I; Wollman E; Payen D; Tedgui A
J Clin Invest; 1992 Mar; 89(3):851-60. PubMed ID: 1541677
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide derived from L-arginine impairs cytoplasmic pH regulation by vacuolar-type H+ ATPases in peritoneal macrophages.
Swallow CJ; Grinstein S; Sudsbury RA; Rotstein OD
J Exp Med; 1991 Nov; 174(5):1009-21. PubMed ID: 1658185
[TBL] [Abstract][Full Text] [Related]
8. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages.
Lepoivre M; Flaman JM; Bobé P; Lemaire G; Henry Y
J Biol Chem; 1994 Aug; 269(34):21891-7. PubMed ID: 7520445
[TBL] [Abstract][Full Text] [Related]
9. Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide-mediated cytostasis.
Nestel FP; Greene RN; Kichian K; Ponka P; Lapp WS
Blood; 2000 Sep; 96(5):1836-43. PubMed ID: 10961884
[TBL] [Abstract][Full Text] [Related]
10. Effect of L-arginine on the retention of macrophage tumoricidal activity.
Takema M; Inaba K; Uno K; Kakihara K; Tawara K; Muramatsu S
J Immunol; 1991 Mar; 146(6):1928-33. PubMed ID: 2005387
[TBL] [Abstract][Full Text] [Related]
11. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells.
Curran RD; Billiar TR; Stuehr DJ; Hofmann K; Simmons RL
J Exp Med; 1989 Nov; 170(5):1769-74. PubMed ID: 2509627
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
13. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
Akiyama Y; Yamasaki T; Fukuda M; Moritake K
No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
[TBL] [Abstract][Full Text] [Related]
14. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.
Lancaster JR; Hibbs JB
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1223-7. PubMed ID: 2153975
[TBL] [Abstract][Full Text] [Related]
15. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst.
Iyengar R; Stuehr DJ; Marletta MA
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6369-73. PubMed ID: 2819872
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.
Drapier JC; Hibbs JB
J Immunol; 1988 Apr; 140(8):2829-38. PubMed ID: 2451695
[TBL] [Abstract][Full Text] [Related]
17. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding AH; Nathan CF; Stuehr DJ
J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
[TBL] [Abstract][Full Text] [Related]
18. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages.
Drapier JC; Pellat C; Henry Y
J Biol Chem; 1991 Jun; 266(16):10162-7. PubMed ID: 1645341
[TBL] [Abstract][Full Text] [Related]
19. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.
Adams LB; Franzblau SG; Vavrin Z; Hibbs JB; Krahenbuhl JL
J Immunol; 1991 Sep; 147(5):1642-6. PubMed ID: 1880420
[TBL] [Abstract][Full Text] [Related]
20. Nitration of angiotensin II by .NO2 radicals and peroxynitrite. .NO protects against .NO2 radical reaction.
Cudic M; Dendane M; Houé-Levin C; Ducrocq C
Eur J Biochem; 1999 Nov; 265(3):967-71. PubMed ID: 10518791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
